(2R,3R,4S,5R,6S)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5R,6S)-3,5,6-trihydroxy-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Term ID

CHEBI:154210

Synonyms

alpha-D-galacto-hexopyranosyl-(1->3)-[alpha-D-galacto-hexopyranosyl-(1->6)]-alpha-D-gluco-hexopyranose
Gal(a1-3)[Gal(a1-6)]a-Glc
WURCS=2.0/2,3,2/[a2122h-1a_1-5][a2112h-1a_1-5]/1-2-2/a3-b1_a6-c1

Definition

References

GlyGen:G79214AG
GlyTouCan:G79214AG

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2R,3R,4S,5R,6S)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5R,6S)-3,5,6-trihydroxy-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype where environments contain (2R,3R,4S,5R,6S)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5R,6S)-3,5,6-trihydroxy-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype modified by environments containing (2R,3R,4S,5R,6S)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5R,6S)-3,5,6-trihydroxy-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype affecting (2R,3R,4S,5R,6S)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5R,6S)-3,5,6-trihydroxy-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Human Disease Model